Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and …

V Muthu, R Agarwal, A Patel, S Kathirvel… - The Lancet Infectious …, 2022 - thelancet.com
Summary COVID-19-associated pulmonary mucormycosis (CAPM) remains an
underdiagnosed entity. Using a modified Delphi method, we have formulated a consensus …

[HTML][HTML] Global prevalence of COVID-19-associated mucormycosis (CAM): living systematic review and meta-analysis

S Hussain, A Riad, A Singh, J Klugarová, B Antony… - Journal of Fungi, 2021 - mdpi.com
Mucormycosis, a secondary fungal infection, gained much attention in the ongoing COVID-
19 pandemic. This deadly infection has a high all-cause mortality rate and imposes a …

[HTML][HTML] The current state of laboratory mycology in Asia/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for …

J Salmanton-García, WY Au, M Hoenigl… - International journal of …, 2023 - Elsevier
Abstract Introduction: Invasive fungal infections (IFIs) in Asia/Pacific are a particular threat to
patients with malignancies, uncontrolled diabetes mellitus or undiagnosed/untreated human …

Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme

L Gouzien, D Che, S Cassaing, O Lortholary… - The Lancet Regional …, 2024 - thelancet.com
Background Mucormycosis is a deadly invasive fungal infection recently included in the
WHO priority pathogen list. Here we sought to describe epidemiological trends of …

Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis

A Watanabe, M So, H Mitaka, Y Ishisaka, H Takagi… - Mycopathologia, 2022 - Springer
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …

Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals

D Seidel, M Simon, R Sprute, M Lubnow, K Evert… - Mycoses, 2022 - Wiley Online Library
Background Most COVID‐19‐associated mucormycosis (CAM) cases are reported from
India and neighbouring countries. Anecdotally cases from Europe have been presented …

An insight into endophytic antimicrobial compounds: An updated analysis

S Digra, S Nonzom - Plant Biotechnology Reports, 2023 - Springer
Resistance in micro-organisms against antimicrobial compounds is an emerging
phenomenon in the modern era as compared to the traditional world which brings new …

Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India–a multi-centre study

M Biswal, P Gupta, R Kanaujia, K Kaur, H Kaur… - Journal of Hospital …, 2022 - Elsevier
Background An unprecedented rise in the number of COVID-19-associated mucormycosis
(CAM) cases has been reported in India. Myriad hypotheses are proposed for the outbreak …

Fungal pathogens and COVID-19

A Singh, A Kaur, A Chowdhary - Current Opinion in Microbiology, 2023 - Elsevier
COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors

A Chowdhary, N Gupta, S Wurster, R Kumar… - Mycoses, 2023 - Wiley Online Library
Background The aetiology of the major outbreak of COVID‐19‐associated mucormycosis
(CAM) in India in spring 2021 remains incompletely understood. Herein, we provide a …